MedPath

Evaluation of 2% progesterone cream efficacy in the treatment of patients with bed sores

Phase 2
Conditions
bed sores.
Pressure ulcer
Registration Number
IRCT20190810044500N24
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
44
Inclusion Criteria

patients with pressure ulcers
Age over 18 years
Satisfaction to participate in the study

Exclusion Criteria

Patients with a variety of female pathological diseases
pregnancy
Patients in critical condition that the relevant specialist does not allow them to participate in the study
Known allergy to progesterone

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of involvement with bed sores. Timepoint: Before the intervention, after completion of the intervention. Method of measurement: clinical examination.;Wound grade in patients. Timepoint: Before the intervention, after completion of the intervention. Method of measurement: clinical examination.;Mean wound size and depth in patients. Timepoint: Before the intervention, after completion of the intervention. Method of measurement: clinical examination.;Existence of infection and discharge from wounds in patients with bed sores. Timepoint: Before the intervention, after completion of the intervention. Method of measurement: clinical examination.;Pain or sensation at the site of the ulcer. Timepoint: Before the intervention, after completion of the intervention. Method of measurement: clinical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath